Seres Therapeutics (MCRB) Earnings
|
Expand Research on MCRB
| Next EPS Date | 8/5/26 | EPS Growth Rate | +93.0% |
|---|---|---|---|
| Average EPS % Beat Rate | -681.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.9% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/5/26  |
Q226 | N/A | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/5/26 | Q126 | -$0.28 | $0.00 | -$0.28 | $360K | N/A | N/A |  | | Details | |
| 11/5/25 |
Q325 | N/A | -$0.04 | N/A | N/A | $7.83M | N/A | N/A | N/A | ||
| 11/5/25 | Q325 | $0.94 | $0.00 | +$0.94 | $350K | N/A | N/A | | | Details | |
| 8/6/25 |
Q225 | -$2.27 | -$0.09 | -$2.18 | N/A | $5M | N/A | | | Details | |
| 5/7/25 |
Q125 | N/A | $0.07 | N/A | N/A | $20M | N/A | N/A | N/A | ||
| 3/13/25 | Q424 | -$0.81 | -$0.20 | -$0.61 | N/A | N/A | N/A | | | Details | |
| 11/13/24 | Q324 | -$0.33 | -$0.08 | -$0.25 | N/A | $25.83M | N/A | | | Details |
